AMY WATKINS: Open Payments
NPI 1568615516 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 39 payments from 9 companies in 2025. Trend: 2023 $424 · 2024 $546 · 2025 $845
Food & beverage: $761Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $427 |
| Janssen Biotech, Inc. | 2 | $105 |
| Celltrion USA Inc. | 2 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Madrigal Pharmaceuticals | 2 | $36 |
| Ardelyx, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| QOL Medical, LLC | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: SKYRIZI, RINVOQ, TREMFYA, VEGZELMA, ENTYVIO, REZDIFFRA, IBSRELA, DUPIXENT.
Industry payments across KS — which companies pay providers there.
